Literature DB >> 1431113

Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines.

N Israël1, M A Gougerot-Pocidalo, F Aillet, J L Virelizier.   

Abstract

We have tested the hypothesis that cellular activation events occurring in T lymphocytes and monocytes and mediated through translocation of the transcription factor NF-kappa B are dependent upon the constitutive redox status of these cells. We used phenolic, lipid-soluble, chain-breaking antioxidants (butylated hydroxyanisole (BHA), nordihydroquairetic acid, or alpha-tocopherol (vitamin E) to show that peroxyl radical scavenging in unstimulated and PMA- or TNF-stimulated cells blocks the functions depending on NF-kappa B activation. BHA was found to suppress not only PMA- or TNF-induced, but also constitutive, HIV-enhancer activity concomitant to an inhibition of NF-kappa B binding activity in both lymphoblastoid T (J.Jhan) and monocytic (U937) cell lines. This was also true for KBF (p50 homodimer) binding activity in U937 cells. Secretion of TNF, the product of another NF-kappa B-dependent gene, was abolished by BHA in PMA-stimulated U937 cells. The anti-oxidative effect of BHA was accompanied by an increase in thiol, but not glutathione, content in stimulated and unstimulated T cell, whereas TNF stimulation itself barely modified the cellular thiol level. Oxidative stress obtained by the addition of H2O2 to the culture medium of J.Jhan or U937 cells could not by itself induce NF-kappa B activation. These observations suggest that TNF and PMA do not lead to NF-kappa B activation through induction of changes in the cell redox status. Rather, TNF and PMA can exert their effect only if cells are in an appropriate redox status, because prior modification toward reduction with BHA treatment prevents this activation. It appears that a basal redox equilibrium tending toward oxidation is a prerequisite for full activation of transduction pathways regulating the activity of NF-kappa B-dependent genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431113

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase.

Authors:  L Zhao; A G Cox; J A Ruzicka; A A Bhat; W Zhang; E W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  The spherulites(TM): a promising carrier for oligonucleotide delivery.

Authors:  N Mignet; A Brun; C Degert; B Delord; D Roux; C Hélène; R Laversanne; J C François
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease.

Authors:  Kelly A Meulendyke; Ceereena Ubaida-Mohien; Julia L Drewes; Zhaohao Liao; Lucio Gama; Kenneth W Witwer; David R Graham; M Christine Zink
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

4.  Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide.

Authors:  Joerg Schreiber; Richard G Jenner; Heather L Murray; Georg K Gerber; David K Gifford; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-04       Impact factor: 11.205

5.  The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.

Authors:  Ryan D Michalek; S Troy Pellom; Beth C Holbrook; Jason M Grayson
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

6.  Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway.

Authors:  M T Anderson; F J Staal; C Gitler; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.

Authors:  S Heck; K Bender; M Kullmann; M Göttlicher; P Herrlich; A C Cato
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

8.  Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages.

Authors:  K A Kelly; M R Hill; K Youkhana; F Wanker; J M Gimble
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6.

Authors:  C E Goldring; S Reveneau; M Algarté; J F Jeannin
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

10.  Constitutive NF-kappa B activity in neurons.

Authors:  C Kaltschmidt; B Kaltschmidt; H Neumann; H Wekerle; P A Baeuerle
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.